Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Ray

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
The American Journal of Cardiology|July 23, 2014
Usefulness of the electrocardiogram in predicting cardiovascular mortality in asymptomatic adults with aortic stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis Study)Anders M Greve, Morten Dalsgaard, Casper N Bang, et al.
Heart (British Cardiac Society)|September 14, 2014
Velocity ratio predicts outcomes in patients with low gradient severe aortic stenosis and preserved EFNikolaus Jander, Willibald Hochholzer, Beat A Kaufmann, et al.
The American Journal of Cardiology|November 25, 2010
Impact of baseline severity of aortic valve stenosis on effect of intensive lipid lowering therapy (from the SEAS study)Eva Gerdts, Anne Bjørhovde Rossebø, Terje Rolf Pedersen, et al.
The American Journal of Cardiology|April 3, 2007
Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) studyAnne B Rossebø, Terje R Pedersen, Christopher Allen, et al.
International Journal of Cardiology|December 2, 2014
Resting heart rate and risk of adverse cardiovascular outcomes in asymptomatic aortic stenosis: the SEAS studyAnders M Greve, Casper N Bang, Ronan M G Berg, et al.
The New England Journal of Medicine|September 4, 2008
Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosisAnne B Rossebø, Terje R Pedersen, Kurt Boman, et al.
Heart (British Cardiac Society)|August 24, 2013
Indexing aortic valve area by body surface area increases the prevalence of severe aortic stenosisNikolaus Jander, Christa Gohlke-Bärwolf, Edda Bahlmann, et al.
European Heart Journal. Cardiovascular Imaging|March 26, 2014
Updated standards and processes for accreditation of echocardiographic laboratories from The European Association of Cardiovascular ImagingBogdan A Popescu, Alexandros Stefanidis, Petros Nihoyannopoulos, et al.
Circulation|February 16, 2011
Outcome of patients with low-gradient "severe" aortic stenosis and preserved ejection fractionNikolaus Jander, Jan Minners, Ingar Holme, et al.
British Journal of Clinical Pharmacology|December 3, 2025
CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx)Cinzia Dello Russo, Iain Frater, Rebecca Kuruvilla, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
The American Journal of Cardiology|July 23, 2014
Usefulness of the electrocardiogram in predicting cardiovascular mortality in asymptomatic adults with aortic stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis Study)Anders M Greve, Morten Dalsgaard, Casper N Bang, et al.
Heart (British Cardiac Society)|September 14, 2014
Velocity ratio predicts outcomes in patients with low gradient severe aortic stenosis and preserved EFNikolaus Jander, Willibald Hochholzer, Beat A Kaufmann, et al.
The American Journal of Cardiology|November 25, 2010
Impact of baseline severity of aortic valve stenosis on effect of intensive lipid lowering therapy (from the SEAS study)Eva Gerdts, Anne Bjørhovde Rossebø, Terje Rolf Pedersen, et al.
The American Journal of Cardiology|April 3, 2007
Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) studyAnne B Rossebø, Terje R Pedersen, Christopher Allen, et al.
International Journal of Cardiology|December 2, 2014
Resting heart rate and risk of adverse cardiovascular outcomes in asymptomatic aortic stenosis: the SEAS studyAnders M Greve, Casper N Bang, Ronan M G Berg, et al.
The New England Journal of Medicine|September 4, 2008
Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosisAnne B Rossebø, Terje R Pedersen, Kurt Boman, et al.
Heart (British Cardiac Society)|August 24, 2013
Indexing aortic valve area by body surface area increases the prevalence of severe aortic stenosisNikolaus Jander, Christa Gohlke-Bärwolf, Edda Bahlmann, et al.
European Heart Journal. Cardiovascular Imaging|March 26, 2014
Updated standards and processes for accreditation of echocardiographic laboratories from The European Association of Cardiovascular ImagingBogdan A Popescu, Alexandros Stefanidis, Petros Nihoyannopoulos, et al.
Circulation|February 16, 2011
Outcome of patients with low-gradient "severe" aortic stenosis and preserved ejection fractionNikolaus Jander, Jan Minners, Ingar Holme, et al.
British Journal of Clinical Pharmacology|December 3, 2025
CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx)Cinzia Dello Russo, Iain Frater, Rebecca Kuruvilla, et al.
Pageof 9